A growing number of Association of Southeast Asian Nations (ASEAN) member states are coming into compliance with medical device requirements they first pledged to work towards in 2015. Under the ASEAN Medical Device Directive (AMDD), the 10 ASEAN nations agreed to bring... Read More
The use of genetic or molecular profiling, known as precision medicine, is growing in popularity and usefulness throughout Asia, as doctors become more adept at selecting treatments that are most likely to help patients based on a genetic understanding of their disease.... Read More
As demand skyrockets for healthcare in Southeast Asia, remote medical provider technologies are becoming increasingly popular. The technologies, which include app-based medical consultations and other telehealth options, allow doctors to reach more patients, especially in remote areas where access to healthcare providers... Read More
This article was originally featured on Medtech Intelligence. As Asia’s prostate cancer burden grows, so do opportunities for Western medical device companies with products to diagnose and treat the disease. Leading Western medical device firms are moving into markets across the Asian... Read More
With Singapore continuing to attract top pharmaceutical companies, clinical research and biomedical manufacturing opportunities abound. Indeed between 2000 and 2015, the number of clinical research programs conducted in Singapore jumped by 30%. Today, six out of the top 10 drugs produced globally... Read More
With rates of hepatitis B infection higher in Asia than anywhere else on the globe, deaths from liver cancer are an overwhelmingly Asian phenomenon. Almost 80 percent of cases and deaths from liver cancer occur on the Asian continent, according to the... Read More
Spending on healthcare is expected to balloon by more than 70% over the next two decades in Malaysia, Indonesia, the Philippines, Singapore, Thailand and Vietnam, according to a report presented at the World Economic Forum. Total healthcare spending in the six nations... Read More
For the first time in a decade, Singapore’s Health Sciences Authority (HSA) is raising the fees it charges to evaluate, register, and license medical devices. The increases, announced in August, are already beginning to take effect. Ranging from $1 to $200 per... Read More
Singapore’s Health Sciences Authority (HSA) is tasked with regulating drugs, innovative therapeutics, medical devices, and other health products to meet appropriate safety, quality, and efficacy standards, as well as contributing to the development of national drug policies. The HSA evaluates product registration... Read More
The Association of Southeast Asian Nations (ASEAN), which is comprised of the countries Indonesia, Malaysia, Philippines, Singapore, Thailand, Vietnam, Brunei, Laos, Myanmar, and Cambodia, was established in 1967 to promote peace and stability in the region, facilitate collaboration and mutual assistance among the... Read More